GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Sale Of Business

Microbix Biosystems (TSX:MBX) Sale Of Business : C$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Sale Of Business?

Microbix Biosystems's sale of business for the three months ended in Mar. 2024 was C$0.00 Mil. It means Microbix Biosystems gained C$0.00 Mil from selling business. Microbix Biosystems's sale of business for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Dec. 2023 ), Microbix Biosystems gained the same money from selling business in Mar. 2024 (C$0.00 Mil).

Microbix Biosystems Sale Of Business Historical Data

The historical data trend for Microbix Biosystems's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Sale Of Business Chart

Microbix Biosystems Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Microbix Biosystems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Microbix Biosystems Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Sale Of Business Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems (TSX:MBX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Sale Of Business
Comparable Companies
TSX:HBP TSX:BCT TSX:MSCL XCNQ:DTC XCNQ:GLAB TSXV:NRX TSXV:TTI TSXV:GSD NEOE:BMND TSXV:COV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
MBXBF:USA
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Website
https://www.microbix.com
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
James Stuart Currie Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines